Lobüler Karsinoma In Sıtu: Tanı ve Tedavisi

Brogi E. The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS. Virchows Arch. 2022;481(6):823-37.

Foote FW, Stewart FW. Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol. 1941;17(4):491-6.3.

Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology. 2020;77(2):181-5.

Shamir ER, Chen YY, Chu T, Pekmezci M, Rabban JT, Krings G. Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center. Am J Surg Pathol. 2019;43(3):399-408.

Cope W, Provenzano E. The diagnosis and management of lobular carcinoma in situ. Diagnostic Histopathology. 2023;29(3):153-61.

King TA, Pilewskie M, Muhsen S, Patil S, Mautner SK, Park A, et al. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk. J Clin Oncol. 2015;33(33):3945-52.

Provenzano E, Pinder SE. Pre-operative diagnosis of breast cancer in screening: problems and pitfalls. Pathology. 2009;41(1):3-17.

Schnitt SJ, Brogi E, Chen YY, King TA, Lakhani SR. American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications. Ann Diagn Pathol. 2020;45:151481.

Kuba MG, Brogi E. Update on lobular lesions of the breast. Histopathology. 2023;82(1):36-52.

Sokolova A, Lakhani SR. Lobular carcinoma in situ: diagnostic criteria and molecular correlates. Mod Pathol. 2021;34(Suppl 1):8-14.

Pinder SE, Shaaban A, Deb R, Desai A, Gandhi A, Lee AHS, et al. NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). Clin Radiol. 2018;73(8):682-92.

van Maaren MC, Ávila AO, van Manen JG, Menke-Pluijmers MB, Veltman J, Bart J, et al. Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis. Breast. 2021;59:376-82.

Baker J, Noguchi N, Marinovich ML, Sprague BL, Salisbury E, Houssami N. Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis. Breast. 2024;78:103807.

Lunt L, Coogan A, Perez CB. Lobular Neoplasia. Surg Clin North Am. 2022;102(6):947-63.

Desai A, Kesmodel SB, Susnik B, Goel N, Feliciano Y, Gomez-Fernandez C, et al. Florid Lobular Carcinoma In Situ: Imaging Characteristics and Pathologic Upgrade Rates on Surgical Excision. Breast J. 2025;2025:3580992.

Masannat YA, Husain E, Roylance R, Heys SD, Carder PJ, Ali H, et al. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ. Breast. 2018;38:120-4.

Li X, Schwartz MR, Ro J, Hamilton CR, Ayala AG, Truong LD, et al. Diagnostic utility of E-cadherin and P120 catenin cocktail immunostain in distinguishing DCIS from LCIS. Int J Clin Exp Pathol. 2014;7(5):2551-7.

Morrogh M, Andrade VP, Giri D, Sakr RA, Paik W, Qin LX, et al. Cadherin-catenin complex dissociation in lobular neoplasia of the breast. Breast Cancer Res Treat. 2012;132(2):641-52.

Bezic J, Gugic D. Signet ring lobular carcinoma in situ as a part of the "Rosen Triad" (tubular carcinoma, columnar cell hyperplasia, and lobular carcinoma in situ). Turk Patoloji Derg. 2013;29(2):134-7.

Gomes DS, Balabram D, Porto SS, Gobbi H. Lobular neoplasia: frequency and association with other breast lesions. Diagn Pathol. 2011;6:74.

Timbres J, Kohut K, Caneppele M, Troy M, Schmidt MK, Roylance R, et al. DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different? Cancers (Basel). 2023;15(17).

Tjendra Y, Susnik B. Non-invasive Lobular Neoplasia: Review and Updates. Semin Diagn Pathol. 2025;42(4):150883.

Begg CB, Ostrovnaya I, Carniello JV, Sakr RA, Giri D, Towers R, et al. Clonal relationships between lobular carcinoma in situ and other breast malignancies. Breast Cancer Res. 2016;18(1):66.

Harrison BT, Nakhlis F, Dillon DA, Soong TR, Garcia EP, Schnitt SJ, et al. Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations. Mod Pathol. 2020;33(7):1287-97.

Brock J. Lobular carcinoma in situ – A pragmatic approach to the controversies. Human Pathology Reports. 2022;27:300589.

Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. Ann Surg Oncol. 2018;25(7):1783-5.